Latest Xaira Therapeutics News & Updates

See the latest news and media coverage for Xaira. We track all announcements, press releases, and industry mentions in real time, all in one place.

Xaira Therapeutics (Xaira)

AI-driven drug discovery company

Latest news about Xaira Therapeutics (Xaira)

March 26 Xaira

Xaira welcomes Rachel Lane as SVP Business Development and Operations

Rachel brings deep biotech and investing experience from Belharra Therapeutics, where she led partnerships with Genentech and Sanofi. She will lead business development and scale AI drug discovery partnerships.
March 25 Xaira

Xaira launches AI in Residence program

It targets recent MS/PhD graduates for 6-12 month projects advancing models like X-Cell. Applications are now open.
March 17 Xaira

Xaira launches X-Cell virtual cell model

X-Cell is trained on the largest genome-wide perturbation dataset and predicts unseen experiment outcomes. It aims to transform drug discovery.
1 October 2025 Xaira

Xaira discusses AI moonshot in biomedicine

Bo Wang, SVP & Head of Biomedical AI at Xaira, joins Endpoints News #AIDay2025 to separate hype from reality and highlight future directions for biomedicine.

March 26 Standard Journal

Xaira Therapeutics Announces the Appointment of Rachel Lane, Ph.D., as Senior Vice President, Business Development and Operations

Xaira Therapeutics today announced the appointment of Dr. Rachel Lane as Senior Vice President, Business Development and Operations, reporting to President and COO Jeff Jonker...
March 23 The Business Journals

Xaira Therapeutics raised nearly $1 billion. Here's its next act

Funders committed nearly $1 billion toward this AI company. Here's its next act.
March 20 Fierce Biotech

Behind the curtain: What Xaira is building after its $1B fundraise

Since Xaira's eye-popping $1 billion fundraise in 2024, the company has said relatively little in public. | What has Xaira been doing since its $1...
March 17 Business Wire

Xaira Therapeutics Launches X-Cell, Its First Virtual Cell Model, Trained on the Largest-Ever Genome-Wide Perturbation Dataset, X-Atlas/Pisces

State-of-the-art AI model accurately predicting unseen biological experiments X-Cell is trained on X-Atlas/Pisces, the largest and most context-diverse genome-wide perturbation dataset ever reported Powered by...

Never miss news about Xaira

Track Xaira and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Browse news for competitors to Xaira and other trending companies.